VDU:CA:TSX-Vanguard FTSE Developed All Cap Ex US (CAD)

ETF | International Equity |

Last Closing

CAD 44.86

Change

-0.17 (-0.38)%

Market Cap

CAD 0.44B

Volume

0.02M

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for International Equity

Symbol Name Price(Change) Market Cap
XEF:CA iShares Core MSCI EAFE IMI

-0.20 (-0.51%)

CAD 8.98B
ZEA:CA BMO MSCI EAFE

-0.09 (-0.38%)

CAD 8.66B
XFH:CA iShares Core MSCI EAFE IMI Ind..

+0.08 (+0.23%)

CAD 1.48B
XIN:CA iShares MSCI EAFE (CAD Hedged)

+0.02 (+0.05%)

CAD 1.39B
QDX:CA Mackenzie International Equity..

+0.04 (+0.03%)

CAD 1.00B
ZDM:CA BMO MSCI EAFE (CAD Hedged)

+0.09 (+0.30%)

CAD 0.89B
VEF:CA Vanguard FTSE Developed All Ca..

-0.01 (-0.02%)

CAD 0.64B
FCIQ:CA Fidelity International High Qu..

-0.05 (-0.13%)

CAD 0.60B
HXDM:CA Global X Intl Developed Market..

-0.20 (-0.41%)

CAD 0.58B
ZDI:CA BMO International Dividend Uni..

+0.01 (+0.04%)

CAD 0.46B

ETFs Containing VDU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (International Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 12.49% 59% D- 54% F
Dividend Return 1.50% 20% F 38% F
Total Return 13.99% 61% D- 53% F
Trailing 12 Months  
Capital Gain 21.67% 81% B- 58% F
Dividend Return 2.44% 36% F 42% F
Total Return 24.11% 67% D+ 57% F
Trailing 5 Years  
Capital Gain 34.39% 54% F 59% D-
Dividend Return 10.97% 50% F 45% F
Total Return 45.36% 66% D+ 59% D-
Average Annual (5 Year Horizon)  
Capital Gain 5.98% N/A N/A 58% F
Dividend Return 8.04% N/A N/A 60% D-
Total Return 2.05% N/A N/A 57% F
Risk Return Profile  
Volatility (Standard Deviation) 13.17% N/A N/A 77% C+
Risk Adjusted Return 61.00% N/A N/A 77% C+
Market Capitalization 0.44B 61% D- 57% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike